News

ASRM Promotes Earlier Infertility Intervention


 

NEW ORLEANS — The American Society for Reproductive Medicine, in collaboration with the Society for Reproductive Endocrinology and Infertility, is revising its definition of infertility to encourage earlier evaluation of women aged over 35 years who have difficulty conceiving.

The new definition, along with a new definition of recurrent pregnancy loss, will be published in the June issue of Fertility and Sterility, Dr. Marc Fritz said at the annual meeting of the American College of Obstetricians and Gynecologists.

ASRM members requested the new definitions, in part because insurers were adhering strictly to the existing guidelines, leading to a denial of access to appropriate treatment, Dr. Fritz said in an interview.

Infertility specialists say that the changes give credence to what's been standard practice in their field. The real impact should come from the word getting out to general ob.gyns. and family physicians, Dr. Eric Surrey, medical director of the Colorado Center for Reproductive Medicine in Lonetree, said in an interview. “This message is meant for the generalist, not the reproductive endocrinologist,” Dr. Masood Khatamee of New York University said in an interview. “And it's a very, very appropriate statement,” he said.

Dr. Fritz agreed that the ASRM was aiming for a broader audience. He said the ASRM will urge early evaluation and treatment of all women based on natural history and physical findings after a failure to achieve pregnancy following at least 12 months of regular unprotected intercourse. Treatment and evaluation will be warranted after 6 months for women aged over 35 years.

The ASRM also for the first time is specifically defining recurrent pregnancy loss as a disease distinct from infertility, said Dr. Fritz, professor of obstetrics and gynecology and division chief of reproductive endocrinology and infertility at the University of North Carolina at Chapel Hill. It will be defined by two or more failed pregnancies; these pregnancies must be documented by ultrasound or pathologic examination. When the cause is unknown, each pregnancy loss merits careful review to determine whether specific evaluations may be appropriate, said Dr. Fritz. After three or more losses, a thorough evaluation is warranted, he said.

Dr. Charles Miller, an infertility specialist in Chicago, said the ASRM “has thrown [its] weight behind what we in the field have done for a while.”

The clear statements on both infertility and recurrent pregnancy loss may also help convince insurance companies to cover evaluation and treatment in instances where they haven't in the past, Dr. Miller said in an interview.

Dr. Surrey agreed that the statements could be helpful for reimbursement. For instance, insurers often consider recurrent pregnancy loss to be a form of infertility, which is inappropriate and untrue, he said in an interview.

He said he was encouraged by the statement on infertility, noting that it will heighten patient and physician awareness that earlier evaluation is important. He said women are often told they have plenty of time to conceive. “That's not what they want to hear,” he said.

The 6-month cut-off for women aged over 35 is a somewhat arbitrary figure, but is necessary to prompt quicker action, said Dr. Surrey. The earlier evaluations may result in more findings of no abnormalities, but at least women will be reassured that they aren't wasting their time if they are told to spend another 6 months trying to conceive, he said.

Dr. Khatamee said he tells other physicians and medical students that a woman's age is a key deciding factor when evaluating infertility. Women over age 35 should not be told to spend a year trying to conceive, he said.

The ASRM favors early evaluation and treatment based on natural history and physical findings. DR. FRITZ

Recommended Reading

Metformin Helps Metabolic Parameters in PCOS
MDedge Endocrinology
Rhubarb Extract Eases Menopausal Hot Flashes
MDedge Endocrinology
Cetrorelix Shows Promise in Prostatic Hyperplasia
MDedge Endocrinology
Irregular Menses Linked to Increased Risk of MI
MDedge Endocrinology
Low-Dose Hormone Combo Brings Relief
MDedge Endocrinology
Neonatal Outcomes Vary With Diabetes Type
MDedge Endocrinology
HAPO Data Link High Glucose to Preeclampsia
MDedge Endocrinology
IVF Tied to Higher Blood Pressure, Fasting Glucose
MDedge Endocrinology
Data Watch: Outcomes of Assisted Reproductive Technology Cycles
MDedge Endocrinology
Aromatase Inhibitor Use In PCOS Needs More Study
MDedge Endocrinology